SUCO and prostate carcinoma: These compounds showed extremely excellent inhibitory activities against human prostate cancer cells (IC50 < 1 μM) in vitro. Among them, CH-1 is the most potential inhibitor which significantly inhibited the tumour growth in vivo. These results indicated that CH-1 is a promising candidate for further exploration.